Articles from Biotech Business (October 1, 2009)

Title	Author	Type	Words
ENDOCYTE GETS MILESTONE PAYMENT FROM BRISTOL-METERS SQUIBB.			307
FDA ACCEPTS SALIX NDA FOR PRIORITY REVIEW.			960
HAWAII BIOTECH BEGINS PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE.			502
PROFECTUS BIOSCIENCES/MVI TO CONDUCT PROOF-OF-CONCEPT STUDY.			451
STEMEDICA REQUESTS PRE-IND MEETING WITH FDA.			333